APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Papaverine Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Papaverine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174022180321 December 2025198 pages

Choose your research edition.

Industry ResearchPapaverine Injection Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Papaverine Injection Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Papaverine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Papaverine Injection Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Papaverine Injection Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Papaverine Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Papaverine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Papaverine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Papaverine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Papaverine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Papaverine Injection include Sandoz, Pude Pharma, Changjiang Pharmaceutical, Jiangsu Hengrui Pharmaceuticals, Hunan Yige Pharmaceutical, Furen Pharmaceutical, Northeast Pharmaceutical Group, Chengdu Brilliant Pharmaceutical and Vulcan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Papaverine Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Papaverine Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Papaverine Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Papaverine Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Papaverine Injection Segment by Company

Sandoz

Pude Pharma

Changjiang Pharmaceutical

Jiangsu Hengrui Pharmaceuticals

Hunan Yige Pharmaceutical

Furen Pharmaceutical

Northeast Pharmaceutical Group

Chengdu Brilliant Pharmaceutical

Vulcan

SGPharma

Oryza Pharmaceuticals

Montage Laboratories

Mercury Laboratories

Cipla

Centurion Healthcare

American Regent

Papaverine Injection Segment by Type

30mg

60mg

Papaverine Injection Segment by Application

Vascular Disease

Gastrointestinal and Biliary Spasms

Papaverine Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Papaverine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Papaverine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Papaverine Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Papaverine Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Papaverine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Papaverine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Papaverine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Papaverine Injection Industry Trends Table 2. Papaverine Injection Industry Drivers Table 3. Papaverine Injection Industry Opportunities and Challenges Table 4. Papaverine Injection Industry Restraints Table 5. Global Papaverine Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Papaverine Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Papaverine Injection Sales by Manufacturers (L) & (2021-2026) Table 8. Global Papaverine Injection Sales Market Share by Manufacturers Table 9. Global Papaverine Injection Average Sales Price (US$/ml) of Manufacturers (2021-2026) Table 10. Global Papaverine Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Papaverine Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Papaverine Injection Manufacturers, Product Type & Application Table 13. Global Papaverine Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Papaverine Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 30mg Table 17. Major Manufacturers of 60mg Table 18. Global Papaverine Injection Sales by Type 2021 VS 2025 VS 2032 (L) Table 19. Global Papaverine Injection Sales by Type (2021-2026) & (L) Table 20. Global Papaverine Injection Sales by Type (2027-2032) & (L) Table 21. Global Papaverine Injection Sales Market Share by Type (2021-2026) Table 22. Global Papaverine Injection Sales Market Share by Type (2027-2032) Table 23. Global Papaverine Injection Revenue by Type 2021 VS 2025 VS 2032 (L) Table 24. Global Papaverine Injection Revenue by Type (2021-2026) & (L) Table 25. Global Papaverine Injection Revenue by Type (2027-2032) & (L) Table 26. Global Papaverine Injection Revenue Market Share by Type (2021-2026) Table 27. Global Papaverine Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Vascular Disease Table 29. Major Manufacturers of Gastrointestinal and Biliary Spasms Table 30. Global Papaverine Injection Sales by Application 2021 VS 2025 VS 2032 (L) Table 31. Global Papaverine Injection Sales by Application (2021-2026) & (L) Table 32. Global Papaverine Injection Sales by Application (2027-2032) & (L) Table 33. Global Papaverine Injection Sales Market Share by Application (2021-2026) Table 34. Global Papaverine Injection Sales Market Share by Application (2027-2032) Table 35. Global Papaverine Injection Revenue by Application 2021 VS 2025 VS 2032 (L) Table 36. Global Papaverine Injection Revenue by Application (2021-2026) & (L) Table 37. Global Papaverine Injection Revenue by Application (2027-2032) & (L) Table 38. Global Papaverine Injection Revenue Market Share by Application (2021-2026) Table 39. Global Papaverine Injection Revenue Market Share by Application (2027-2032) Table 40. Global Papaverine Injection Sales by Region: 2021 VS 2025 VS 2032 (L) Table 41. Global Papaverine Injection Sales by Region (2021-2026) & (L) Table 42. Global Papaverine Injection Sales Market Share by Region (2021-2026) Table 43. Global Papaverine Injection Sales Forecasted by Region (2027-2032) & (L) Table 44. Global Papaverine Injection Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Papaverine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 46. North America Papaverine Injection Sales by Country (2021-2026) & (L) Table 47. North America Papaverine Injection Sales by Country (2027-2032) & (L) Table 48. Europe Papaverine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 49. Europe Papaverine Injection Sales by Country (2021-2026) & (L) Table 50. Europe Papaverine Injection Sales by Country (2027-2032) & (L) Table 51. Asia Pacific Papaverine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 52. Asia Pacific Papaverine Injection Sales by Country (2021-2026) & (L) Table 53. Asia Pacific Papaverine Injection Sales by Country (2027-2032) & (L) Table 54. South America, Middle East and Africa Papaverine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 55. South America, Middle East and Africa Papaverine Injection Sales by Country (2021-2026) & (L) Table 56. South America, Middle East and Africa Papaverine Injection Sales by Country (2027-2032) & (L) Table 57. Global Papaverine Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Papaverine Injection Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Papaverine Injection Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Papaverine Injection Revenue Market Share by Region (2021-2026) Table 61. Global Papaverine Injection Revenue Market Share by Region (2027-2032) Table 62. Sandoz Company Information Table 63. Sandoz Business Overview Table 64. Sandoz Papaverine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Sandoz Papaverine Injection Product Portfolio Table 66. Sandoz Recent Development Table 67. Pude Pharma Company Information Table 68. Pude Pharma Business Overview Table 69. Pude Pharma Papaverine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Pude Pharma Papaverine Injection Product Portfolio Table 71. Pude Pharma Recent Development Table 72. Changjiang Pharmaceutical Company Information Table 73. Changjiang Pharmaceutical Business Overview Table 74. Changjiang Pharmaceutical Papaverine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Changjiang Pharmaceutical Papaverine Injection Product Portfolio Table 76. Changjiang Pharmaceutical Recent Development Table 77. Jiangsu Hengrui Pharmaceuticals Company Information Table 78. Jiangsu Hengrui Pharmaceuticals Business Overview Table 79. Jiangsu Hengrui Pharmaceuticals Papaverine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Jiangsu Hengrui Pharmaceuticals Papaverine Injection Product Portfolio Table 81. Jiangsu Hengrui Pharmaceuticals Recent Development Table 82. Hunan Yige Pharmaceutical Company Information Table 83. Hunan Yige Pharmaceutical Business Overview Table 84. Hunan Yige Pharmaceutical Papaverine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Hunan Yige Pharmaceutical Papaverine Injection Product Portfolio Table 86. Hunan Yige Pharmaceutical Recent Development Table 87. Furen Pharmaceutical Company Information Table 88. Furen Pharmaceutical Business Overview Table 89. Furen Pharmaceutical Papaverine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Furen Pharmaceutical Papaverine Injection Product Portfolio Table 91. Furen Pharmaceutical Recent Development Table 92. Northeast Pharmaceutical Group Company Information Table 93. Northeast Pharmaceutical Group Business Overview Table 94. Northeast Pharmaceutical Group Papaverine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Northeast Pharmaceutical Group Papaverine Injection Product Portfolio Table 96. Northeast Pharmaceutical Group Recent Development Table 97. Chengdu Brilliant Pharmaceutical Company Information Table 98. Chengdu Brilliant Pharmaceutical Business Overview Table 99. Chengdu Brilliant Pharmaceutical Papaverine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Chengdu Brilliant Pharmaceutical Papaverine Injection Product Portfolio Table 101. Chengdu Brilliant Pharmaceutical Recent Development Table 102. Vulcan Company Information Table 103. Vulcan Business Overview Table 104. Vulcan Papaverine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Vulcan Papaverine Injection Product Portfolio Table 106. Vulcan Recent Development Table 107. SGPharma Company Information Table 108. SGPharma Business Overview Table 109. SGPharma Papaverine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. SGPharma Papaverine Injection Product Portfolio Table 111. SGPharma Recent Development Table 112. Oryza Pharmaceuticals Company Information Table 113. Oryza Pharmaceuticals Business Overview Table 114. Oryza Pharmaceuticals Papaverine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Oryza Pharmaceuticals Papaverine Injection Product Portfolio Table 116. Oryza Pharmaceuticals Recent Development Table 117. Montage Laboratories Company Information Table 118. Montage Laboratories Business Overview Table 119. Montage Laboratories Papaverine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Montage Laboratories Papaverine Injection Product Portfolio Table 121. Montage Laboratories Recent Development Table 122. Mercury Laboratories Company Information Table 123. Mercury Laboratories Business Overview Table 124. Mercury Laboratories Papaverine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Mercury Laboratories Papaverine Injection Product Portfolio Table 126. Mercury Laboratories Recent Development Table 127. Cipla Company Information Table 128. Cipla Business Overview Table 129. Cipla Papaverine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Cipla Papaverine Injection Product Portfolio Table 131. Cipla Recent Development Table 132. Centurion Healthcare Company Information Table 133. Centurion Healthcare Business Overview Table 134. Centurion Healthcare Papaverine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Centurion Healthcare Papaverine Injection Product Portfolio Table 136. Centurion Healthcare Recent Development Table 137. American Regent Company Information Table 138. American Regent Business Overview Table 139. American Regent Papaverine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. American Regent Papaverine Injection Product Portfolio Table 141. American Regent Recent Development Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Papaverine Injection Distributors List Table 145. Papaverine Injection Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Papaverine Injection Product Image Figure 2. Global Papaverine Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Papaverine Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Papaverine Injection Sales (2021-2032) & (L) Figure 5. Global Papaverine Injection Average Price (US$/ml) & (2021-2032) Figure 6. Global Top 5 and 10 Papaverine Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 30mg Image Figure 9. 60mg Image Figure 10. Global Papaverine Injection Sales by Type (2021 VS 2025 VS 2032) & (L) Figure 11. Global Papaverine Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Papaverine Injection Sales Market Share by Type (2021-2032) Figure 13. Global Papaverine Injection Revenue by Type (2021 VS 2025 VS 2032) & (L) Figure 14. Global Papaverine Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Papaverine Injection Revenue Market Share by Type (2021-2032) Figure 16. Vascular Disease Image Figure 17. Gastrointestinal and Biliary Spasms Image Figure 18. Global Papaverine Injection Sales by Application (2021 VS 2025 VS 2032) & (L) Figure 19. Global Papaverine Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Papaverine Injection Sales Market Share by Application (2021-2032) Figure 21. Global Papaverine Injection Revenue by Application (2021 VS 2025 VS 2032) & (L) Figure 22. Global Papaverine Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Papaverine Injection Revenue Market Share by Application (2021-2032) Figure 24. North America Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 25. North America Papaverine Injection Sales Market Share by Country (2021-2032) Figure 26. U.S. Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 27. Canada Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 28. Mexico Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 29. Europe Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 30. Europe Papaverine Injection Sales Market Share by Country (2021-2032) Figure 31. Germany Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 32. France Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 33. U.K. Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 34. Italy Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 35. Netherlands Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 36. Asia Pacific Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 37. Asia Pacific Papaverine Injection Sales Market Share by Country (2021-2032) Figure 38. China Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 39. Japan Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 40. South Korea Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 41. Southeast Asia Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 42. India Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 43. Australia Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 44. South America, Middle East and Africa Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 45. South America, Middle East and Africa Papaverine Injection Sales Market Share by Country (2021-2032) Figure 46. Brazil Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 47. South Africa Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 48. Saudi Arabia Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 49. Turkey Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 50. Argentina Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 51. UAE Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 52. Egypt Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 53. Chile Papaverine Injection Sales and Growth Rate (2021-2032) & (L) Figure 54. Global Papaverine Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Papaverine Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Papaverine Injection Revenue (2021-2032) & (US$ Million) Figure 57. North America Papaverine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Papaverine Injection Revenue (2021-2032) & (US$ Million) Figure 59. Europe Papaverine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Papaverine Injection Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Papaverine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Papaverine Injection Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Papaverine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Papaverine Injection Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Papaverine Injection Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 30mg
  • 60mg
Applications
  • Vascular Disease
  • Gastrointestinal and Biliary Spasms
Companies covered
  • Sandoz
  • Pude Pharma
  • Changjiang Pharmaceutical
  • Jiangsu Hengrui Pharmaceuticals
  • Hunan Yige Pharmaceutical
  • Furen Pharmaceutical
  • Northeast Pharmaceutical Group
  • Chengdu Brilliant Pharmaceutical
  • Vulcan
  • SGPharma
  • Oryza Pharmaceuticals
  • Montage Laboratories
  • Mercury Laboratories
  • Cipla
  • Centurion Healthcare
  • American Regent

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Papaverine Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Papaverine Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Papaverine Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Papaverine Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Papaverine Injection Market Dynamics
  1. 2.1 Papaverine Injection Industry Trends
  2. 2.2 Papaverine Injection Industry Drivers
  3. 2.3 Papaverine Injection Industry Opportunities and Challenges
  4. 2.4 Papaverine Injection Industry Restraints
3 Papaverine Injection Market by Manufacturers
  1. 3.1 Global Papaverine Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Papaverine Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Papaverine Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Papaverine Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Papaverine Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Papaverine Injection Manufacturers, Product Type & Application
  7. 3.7 Global Papaverine Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Papaverine Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Papaverine Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Papaverine Injection Tier 1, Tier 2, and Tier 3
4 Papaverine Injection Market by Type
  1. 4.1 Papaverine Injection Type Introduction
  2. 4.1.1 30mg
  3. 4.1.2 60mg
  4. 4.2 Global Papaverine Injection Sales by Type
  5. 4.2.1 Global Papaverine Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Papaverine Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Papaverine Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Papaverine Injection Revenue by Type
  9. 4.3.1 Global Papaverine Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Papaverine Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Papaverine Injection Revenue Market Share by Type (2021-2032)
5 Papaverine Injection Market by Application
  1. 5.1 Papaverine Injection Application Introduction
  2. 5.1.1 Vascular Disease
  3. 5.1.2 Gastrointestinal and Biliary Spasms
  4. 5.2 Global Papaverine Injection Sales by Application
  5. 5.2.1 Global Papaverine Injection Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Papaverine Injection Sales by Application (2021-2032)
  7. 5.2.3 Global Papaverine Injection Sales Market Share by Application (2021-2032)
  8. 5.3 Global Papaverine Injection Revenue by Application
  9. 5.3.1 Global Papaverine Injection Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Papaverine Injection Revenue by Application (2021-2032)
  11. 5.3.3 Global Papaverine Injection Revenue Market Share by Application (2021-2032)
6 Global Papaverine Injection Sales by Region
  1. 6.1 Global Papaverine Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Papaverine Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Papaverine Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Papaverine Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Papaverine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Papaverine Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Papaverine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Papaverine Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Papaverine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Papaverine Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Papaverine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Papaverine Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Papaverine Injection Revenue by Region
  1. 7.1 Global Papaverine Injection Revenue by Region
  2. 7.1.1 Global Papaverine Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Papaverine Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Papaverine Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Papaverine Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Papaverine Injection Revenue (2021-2032)
  8. 7.2.2 North America Papaverine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Papaverine Injection Revenue (2021-2032)
  11. 7.3.2 Europe Papaverine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Papaverine Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Papaverine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Papaverine Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Papaverine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sandoz
  2. 8.1.1 Sandoz Company Information
  3. 8.1.2 Sandoz Business Overview
  4. 8.1.3 Sandoz Papaverine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sandoz Papaverine Injection Product Portfolio
  6. 8.1.5 Sandoz Recent Developments
  7. 8.2 Pude Pharma
  8. 8.2.1 Pude Pharma Company Information
  9. 8.2.2 Pude Pharma Business Overview
  10. 8.2.3 Pude Pharma Papaverine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pude Pharma Papaverine Injection Product Portfolio
  12. 8.2.5 Pude Pharma Recent Developments
  13. 8.3 Changjiang Pharmaceutical
  14. 8.3.1 Changjiang Pharmaceutical Company Information
  15. 8.3.2 Changjiang Pharmaceutical Business Overview
  16. 8.3.3 Changjiang Pharmaceutical Papaverine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Changjiang Pharmaceutical Papaverine Injection Product Portfolio
  18. 8.3.5 Changjiang Pharmaceutical Recent Developments
  19. 8.4 Jiangsu Hengrui Pharmaceuticals
  20. 8.4.1 Jiangsu Hengrui Pharmaceuticals Company Information
  21. 8.4.2 Jiangsu Hengrui Pharmaceuticals Business Overview
  22. 8.4.3 Jiangsu Hengrui Pharmaceuticals Papaverine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Jiangsu Hengrui Pharmaceuticals Papaverine Injection Product Portfolio
  24. 8.4.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
  25. 8.5 Hunan Yige Pharmaceutical
  26. 8.5.1 Hunan Yige Pharmaceutical Company Information
  27. 8.5.2 Hunan Yige Pharmaceutical Business Overview
  28. 8.5.3 Hunan Yige Pharmaceutical Papaverine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hunan Yige Pharmaceutical Papaverine Injection Product Portfolio
  30. 8.5.5 Hunan Yige Pharmaceutical Recent Developments
  31. 8.6 Furen Pharmaceutical
  32. 8.6.1 Furen Pharmaceutical Company Information
  33. 8.6.2 Furen Pharmaceutical Business Overview
  34. 8.6.3 Furen Pharmaceutical Papaverine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Furen Pharmaceutical Papaverine Injection Product Portfolio
  36. 8.6.5 Furen Pharmaceutical Recent Developments
  37. 8.7 Northeast Pharmaceutical Group
  38. 8.7.1 Northeast Pharmaceutical Group Company Information
  39. 8.7.2 Northeast Pharmaceutical Group Business Overview
  40. 8.7.3 Northeast Pharmaceutical Group Papaverine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Northeast Pharmaceutical Group Papaverine Injection Product Portfolio
  42. 8.7.5 Northeast Pharmaceutical Group Recent Developments
  43. 8.8 Chengdu Brilliant Pharmaceutical
  44. 8.8.1 Chengdu Brilliant Pharmaceutical Company Information
  45. 8.8.2 Chengdu Brilliant Pharmaceutical Business Overview
  46. 8.8.3 Chengdu Brilliant Pharmaceutical Papaverine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Chengdu Brilliant Pharmaceutical Papaverine Injection Product Portfolio
  48. 8.8.5 Chengdu Brilliant Pharmaceutical Recent Developments
  49. 8.9 Vulcan
  50. 8.9.1 Vulcan Company Information
  51. 8.9.2 Vulcan Business Overview
  52. 8.9.3 Vulcan Papaverine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Vulcan Papaverine Injection Product Portfolio
  54. 8.9.5 Vulcan Recent Developments
  55. 8.10 SGPharma
  56. 8.10.1 SGPharma Company Information
  57. 8.10.2 SGPharma Business Overview
  58. 8.10.3 SGPharma Papaverine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 SGPharma Papaverine Injection Product Portfolio
  60. 8.10.5 SGPharma Recent Developments
  61. 8.11 Oryza Pharmaceuticals
  62. 8.11.1 Oryza Pharmaceuticals Company Information
  63. 8.11.2 Oryza Pharmaceuticals Business Overview
  64. 8.11.3 Oryza Pharmaceuticals Papaverine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Oryza Pharmaceuticals Papaverine Injection Product Portfolio
  66. 8.11.5 Oryza Pharmaceuticals Recent Developments
  67. 8.12 Montage Laboratories
  68. 8.12.1 Montage Laboratories Company Information
  69. 8.12.2 Montage Laboratories Business Overview
  70. 8.12.3 Montage Laboratories Papaverine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Montage Laboratories Papaverine Injection Product Portfolio
  72. 8.12.5 Montage Laboratories Recent Developments
  73. 8.13 Mercury Laboratories
  74. 8.13.1 Mercury Laboratories Company Information
  75. 8.13.2 Mercury Laboratories Business Overview
  76. 8.13.3 Mercury Laboratories Papaverine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Mercury Laboratories Papaverine Injection Product Portfolio
  78. 8.13.5 Mercury Laboratories Recent Developments
  79. 8.14 Cipla
  80. 8.14.1 Cipla Company Information
  81. 8.14.2 Cipla Business Overview
  82. 8.14.3 Cipla Papaverine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Cipla Papaverine Injection Product Portfolio
  84. 8.14.5 Cipla Recent Developments
  85. 8.15 Centurion Healthcare
  86. 8.15.1 Centurion Healthcare Company Information
  87. 8.15.2 Centurion Healthcare Business Overview
  88. 8.15.3 Centurion Healthcare Papaverine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Centurion Healthcare Papaverine Injection Product Portfolio
  90. 8.15.5 Centurion Healthcare Recent Developments
  91. 8.16 American Regent
  92. 8.16.1 American Regent Company Information
  93. 8.16.2 American Regent Business Overview
  94. 8.16.3 American Regent Papaverine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 American Regent Papaverine Injection Product Portfolio
  96. 8.16.5 American Regent Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Papaverine Injection Value Chain Analysis
  2. 9.1.1 Papaverine Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Papaverine Injection Production Mode & Process
  6. 9.2 Papaverine Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Papaverine Injection Distributors
  9. 9.2.3 Papaverine Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst